COVID-19 residual symptoms and adverse drug reactions after oral antiviral therapy in the Singapore primary care setting

COVID-19 residual symptoms and adverse drug reactions after oral antiviral therapy in the Singapore primary care setting

The COVID-19 pandemic remains a significant public health threat with over 7 million deaths worldwide (as of 14 January 2024).1 In Singapore, oral antivirals (OAVs) nirmatrelvir/ritonavir and molnupiravir were approved in 2022 for treating mild-to-moderate COVID-19 in adults at risk of progression...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia Qi Yeo, Poh Ching Tan, Cheryl Wei Yan Tan, Poay Sian Sabrina Lee
Format: Article
Language:English
Published: Academy of Medicine Singapore 2024-12-01
Series:Annals, Academy of Medicine, Singapore
Online Access:https://annals.edu.sg/covid-19-residual-symptoms-and-adverse-drug-reactions-after-oral-antiviral-therapy-in-the-singapore-primary-care-setting/
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://annals.edu.sg/covid-19-residual-symptoms-and-adverse-drug-reactions-after-oral-antiviral-therapy-in-the-singapore-primary-care-setting/

Similar Items